Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01707420 · ClinicalTrials.gov registry record · NA

Preoperative Gabapentin for Post-tonsillectomy Pain in Children

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT01707420: Completed NA study, sponsored by University of Colorado, Denver.

NCT01707420 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01707420, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

The typical post-operative course for children following surgical removal of their tonsils and adenoids can be challenging, especially for pain control. First line medications for pain include intravenous and enteral narcotics, acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) or N-methyl-D-aspartate (NMDA) antagonists but their effects appear to be short-lived. Gabapentin has been shown in adult studies to tone down the body's response to pain and decreases opioid use post-operatively. The purpose of this study is to see if a single preoperative dose will reduce post-operative pain scores and the amount of analgesic used.

Primary Outcome

Total mean oral analgesic requirement (cumulative hydrocodone dose (mg/kg)) at nine time points between 0 and 36 hrs post operatively.

Interventions

  • DRUG Gabapentin
  • DRUG liquid placebo

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2012-08
Est. Completion 2015-12
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT01707420 record still lists

NCT01707420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Gabapentin is the first listed.

NCT01707420 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01707420 about?

NCT01707420 is a clinical study titled "Preoperative Gabapentin for Post-tonsillectomy Pain in Children". The typical post-operative course for children following surgical removal of their tonsils and adenoids can be challenging, especially for pain control. First line medications for pain include intravenous and enteral narcotics, acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) or N-met...

What is the current status of trial NCT01707420?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2012-08. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01707420?

The interventions under investigation include: Gabapentin (DRUG), liquid placebo (DRUG).

Who is sponsoring clinical trial NCT01707420?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01707420's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01707420, the US trial registry maintained by the National Library of Medicine. NCT01707420 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.